- Israeli headquarters with US presence.
- SipNose is based on a professional and experienced team that combines expertise in technology, engineering, medical applications and science together with managing and product development proficiency.
Dr. Iris Shichor
Dr. Shichor brings to SipNose her extensive experience in leading research and development programs and managing product development projects from concept to product.Dr. Shichor holds a Ph.D. from the Hebrew University of Jerusalem with strong expertise in biochemistry and physiology, neuroscience and drug delivery systems.Before co-founding SipNose, Dr. Shichor was VP R&D at ClearFarma.Her previous experience includes a post-doctoral fellowship in the laboratory of Prof. Robert Langer (Harvard-MIT Division of Health Sciences and Technology (HST) where she focused on controlled release local anesthetic formulations, and a position as a senior scientist and project leader at NanoCyte Ltd. where she developed an innovative platform technology for transdermal delivery.
Mr. Daniel Shahaf
Mr. Daniel Shahaf brings to SipNose years of extensive experience as a successful inventor, developer and entrepreneur in the field of medical platforms for the human respiratory system. Mr. Shahaf brings a vast understanding of stress elimination significance in respiratory drug applications. Prior to co-founding SipNose, Mr. Shahaf lead the development and engineering of several projects in the field of nanotechnology based diagnostics at the Alfred Man institute at the Technion institute of technology, Israel. Mr. Shahaf brings a vast experience in managing product development projects and consulting in a broad range of industrial projects around the world. Education: Animal physiology- the faculty of agriculture, Hebrew University of Jerusalem.
Mr. Eric Keller
Senior Business and Strategy Advisor
Mr. Eric Keller is Senior Business and Strategy Advisor to SipNose. He is a proven business and legal executive with nearly 30 years professional experience with expertise that spans all areas of media and technology, including software, materials science, nanotechnology, and life sciences. He is the Founder and CEO of Redux Therapeutics, a clinical stage drug development company, and Co-Founder and Director of C2Sense, Inc, an innovative gas sensing company started out of MIT. Previously, he was the Co-Founder and CEO at Nano Terra, a Boston-based nanotechnology company. Mr. Keller graduated with an A.B. from Harvard College and a J.D. from Boston College, and practiced securities, venture capital, and technology company law in Boston and Washington, DC.
Dr. Liron Hadar
VP Product Development and RA
Dr. Liron Hadar brings to SipNose her extensive multidisciplinary knowhow in global project management and system development of medical devices and combination products. Dr. Hadar holds a Ph.D. in Chemical Engineering from the Technion– Israel Institute of Technology. Following her Ph.D. Liron was a postdocoral fellow at the Biomedical Engineering department at the Technion, at the Tissue Engineering laboratory. Prior joining SipNose Dr. Hadar served as the CEO of Gynamics and RapiDx, start-ups developing medical devices. Before that Dr. Hadar served as the R&D Director at SmartZyme Biopharma, Director of Engineering and New Products Development at LabStyle (Dario Health) and R&D Manager at Medingo, a company acquired by Roche.H
Mrs. Kaufman brings to SipNose her extensive experience in managing production processes in industrial environments, both for biotech and high-tech industries. Mrs. Kaufman brings her vast experience in adapting solutions to various interfaces. Mrs. Kaufman is a Practical engineer in her training and in her previous roles she managed production and operation, and was actively involved in the technological development of production processes and transfer to production activities, maintaining quality in compliance with the company’s goals. Prior joining SipNose, Mrs. Kaufman served as Operation Manager at Scopustech LTD. and as Production and Operation Manager at MTRE (acquired by Mennen Medical).
Board of Directors
- Moshe Mizrahy
- Meir Shamir
- Iftah Poran
- Ariel Meyuhas
- Hadar Ron, PhD
Scientific Advisory Board
- Professor Avraham Karasik, MD. Formerly head of Endocrinology and past Chairman of Medicine at the Sheba Medical Centre Israel
- Professor Tamir Ben-Hur, MD. PhD. – Formerly Head of Department of Neurology, Hadassah Medical Center, Jerusalem.
- Professor Natan Bornstein, MD. – Head of Stroke Unit, Neurology Department, Tel Aviv Sourasky Medical Center and professor of Neurology at the Tel Aviv University, Sackler Faculty of Medicine.